The historic rise of Viagra has firmly established as a benchmark of pharmaceutical success, but its position within the broader sector now triggers questions about potential yields . Alternative versions are undercutting exclusivity check here , prompting concerns that investing in companies closely tied to Viagra's previous influence could be a d